8d
GlobalData on MSNFDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKDThe Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic ...
In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...
Fasting from dawn to dusk during Ramadan can be a challenge for many, especially when it comes to staying energised ...
Axsome Therapeutics (AXSM) has received formal pre-New Drug Application meeting minutes from the U.S. Food and Drug Administration supporting a ...
Cardiorenal specialist scPharmaceuticals has won US Food and Drug Administration (FDA) approval for its supplemental New Drug Application (sNDA) for Furoscix (furosemide injection) to expand the ...
This article is part of your SHN+ subscription In 2025, the baby boomer generation is standing at the industry’s doorstep.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
The Californian company earlier announced the US Food and Drug Administration’s (FDA) acceptance of a supplemental New Drug Application (sNDA) for Zoryve (roflumilast) cream 0.05%, a once-daily, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results